Literature DB >> 33411572

Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Pongsapak Wongratwanich1, Kiichi Shimabukuro1, Masaru Konishi2, Toshikazu Nagasaki1, Masahiko Ohtsuka1, Yoshikazu Suei2, Takashi Nakamoto1, Rinus G Verdonschot1, Tomohiko Kanesaki3, Pipop Sutthiprapaporn4, Naoya Kakimoto1.   

Abstract

OBJECTIVE: Patients with medication-related osteonecrosis of the jaw (MRONJ) often visit their dentists at advanced stages and subsequently require treatments that greatly affect quality of life. Currently, no clear diagnostic criteria exist to assess MRONJ, and the definitive diagnosis solely relies on clinical bone exposure. This ambiguity leads to a diagnostic delay, complications, and unnecessary burden. This article aims to identify imaging modalities' usage and findings of MRONJ to provide possible approaches for early detection.
METHODS: Literature searches were conducted using PubMed, Web of Science, Scopus, and Cochrane Library to review all diagnostic imaging modalities for MRONJ.
RESULTS: Panoramic radiography offers a fundamental understanding of the lesions. Imaging findings were comparable between non-exposed and exposed MRONJ, showing osteolysis, osteosclerosis, and thickened lamina dura. Mandibular cortex index Class II could be a potential early MRONJ indicator. While three-dimensional modalities, CT and CBCT, were able to show more features unique to MRONJ such as a solid type periosteal reaction, buccal predominance of cortical perforation, and bone-within-bone appearance. MRI signal intensities of vital bones are hypointense on T1WI and hyperintense on T2WI and STIR when necrotic bone shows hypointensity on all T1WI, T2WI, and STIR. Functional imaging is the most sensitive method but is usually performed in metastasis detection rather than being a diagnostic tool for early MRONJ.
CONCLUSION: Currently, MRONJ-specific imaging features cannot be firmly established. However, the current data are valuable as it may lead to a more efficient diagnostic procedure along with a more suitable selection of imaging modalities.

Entities:  

Keywords:  Bisphosphonate-Associated Osteonecrosis of the Jaw; Radiography, Panoramic; Tomography, X-Ray Computed; cone-beam computed tomography; magnetic resonance imaging

Mesh:

Substances:

Year:  2021        PMID: 33411572      PMCID: PMC8404513          DOI: 10.1259/dmfr.20200417

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   3.525


  104 in total

1.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  Computed tomography imaging features of osteomyelitis of the jaw: comparison between antiresorptive medication-related conditions and medication-unrelated conditions.

Authors:  Jeong Won Shin; Jo-Eun Kim; Kyung-Hoe Huh; Won-Jin Yi; Min-Suk Heo; Sam-Sun Lee; Soon-Chul Choi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2019-11-14

3.  Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.

Authors:  Alberto Bedogni; Giorgia Saia; Giordana Bettini; Anita Tronchet; Andrea Totola; Giorgio Bedogni; Giuseppe Ferronato; Pier Francesco Nocini; Stella Blandamura
Journal:  Oral Oncol       Date:  2011-03-24       Impact factor: 5.337

4.  The role of magnetic resonance imaging and scintigraphy in the diagnosis of pathologic changes of the mandible after radiation therapy.

Authors:  G Bachmann; R Rössler; R Klett; W S Rau; R Bauer
Journal:  Int J Oral Maxillofac Surg       Date:  1996-06       Impact factor: 2.789

5.  Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.

Authors:  Taggreed Wazzan; Deeba Kashtwari; Wejood F Almaden; Yan Gong; Yiqing Chen; Jan Moreb; Joseph Katz
Journal:  Spec Care Dentist       Date:  2018-09-08

Review 6.  The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis.

Authors:  M F Termaat; P G H M Raijmakers; H J Scholten; F C Bakker; P Patka; H J T M Haarman
Journal:  J Bone Joint Surg Am       Date:  2005-11       Impact factor: 5.284

Review 7.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Panoramic radiographic features that predict the development of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Ryota Kubo; Yoshiko Ariji; Tohru Taniguchi; Michihito Nozawa; Akitoshi Katsumata; Eiichiro Ariji
Journal:  Oral Radiol       Date:  2017-06-12       Impact factor: 1.852

9.  Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.

Authors:  Alexandre T Assaf; Tomislav A Zrnc; Chressen C Remus; Gerhard Adam; Jozef Zustin; Max Heiland; Reinhard E Friedrich; Thorsten Derlin
Journal:  J Craniomaxillofac Surg       Date:  2015-06-27       Impact factor: 2.078

10.  Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: Osteoradionecrosis versus medication-related osteonecrosis of the jaw.

Authors:  Ichiro Ogura; Yoshihiko Sasaki; Mikiko Sue; Takaaki Oda; Ayako Kameta; Kazuhide Hayama
Journal:  Imaging Sci Dent       Date:  2019-03-25
View more
  1 in total

1.  Correlation of dynamic contrast-enhanced bone perfusion with morphologic ultra-short echo time MR imaging in medication-related osteonecrosis of the jaw.

Authors:  Paul Schumann; Sarah Morgenroth; Florian A Huber; Niels J Rupp; Filippo Del Grande; Roman Guggenberger
Journal:  Dentomaxillofac Radiol       Date:  2021-08-18       Impact factor: 2.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.